AMY FIESSINGER: Open Payments
NPI 1578751533 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$69 in 3 payments from 3 companies in 2025. Trend: 2023 $184 · 2024 $15 · 2025 $69
Food & beverage: $69
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $28 |
| ACADIA Pharmaceuticals Inc | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: INGREZZA, NUPLAZID, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
